Funding

  • 2022-2027
    Israel Science Foundation (ISF) “MRI of iron metabolism and iron based reporter probes” 
  • 2021-2023
    Weizmann Sourasky Fund “MRI of adaptation to hypoxia in pregnancy” ( coPI Dafna Ben Bashat, Sourasky Medical Center)
  • 2020-2021
    Israel Science Foundation; KillCorona - Curbing coronavirus (SARS-CoV-2) Research program “The Effects of COVID-19 on Placental Characteristics and Pregnancy Complications” (coPIs Michal Kovo, Wolfson Med Cen; Simcha Yagel, Hadassah Med Cen; Ariel Many, Sourasky Med Cen). 
  • 2016-2021
    NIH R01 “Integrated Placental Imaging: Novel Methods For Probing Function
    And Metabolism” ( coPI Joel Garbow, Washington University St Louis)
  • 2015-2019
    Ministry of Science and Technology “Ferritin nanocage engineering toward in
    vivo auto-produced MRI contrast agent” (coPI Raz Zarivach, Ben Gurion University).
  • 2014-2018
    Israel Academy of Science, Functional and Molecular regulation of
    lymphangiogenesis      (PI, CoPI Batya Cohen)
  • 2012-2015
    BSF | Placental imaging (coPI Joel Garbow, Washington University St Louis)
  • 2011-2016
    NIH RO1 | MRI studies of angiogenesis in ovarian cancer.
  • 2008-2013
    EU-FP7 ERC Advanced: Imaging Regulatory Pathways of Angiogenesis (IMAGO).
  • 2008-2012
    EU-FP7 ENCITE, European Network for Cell Imaging and Tracking Expertise
    (led by EIBIR).
  • 2008
    Gurwin Foundation Novel targeted agents for molecular imaging of
    ovarian carcinoma
  • 2007
    Equipment funding, ISF Converging technologies:
    Multimodality Platform for Cellular and Molecular Preclinical Imaging
    (PI, coPIs Alon Harmelin, Ronen Basri)
  • 2007-2011
    Israel Academy of Science, Functional and Molecular regulation of
    lymphangiogenesis      (PI, CoPI Batya Cohen)
  • 2007-2008
    Yeda CEO fund, Novel targeted agents for molecular imaging of ovarian
    carcinoma    , (PI, CoPI Fortune Kohen)
  • 2007-2008
    The Clore Foundation, Exploring the use of R2/R1 NMRD as a Contrast
    Mechanism for Molecular and Cellular Imaging by multi-field MRI
  • 2007-2011
    EU-FP6 MEDITRANS, Targeted Delivery of Nanomedicine
    (Integrated Project, led by Gert Storm, Univ. Utrecht).
  • 2007-2010
    DKFZ-Israel MRI detection of Molecular targeting of tumor angiogenesis
    (with Fabian Kiessling, DKFZ).
  • 2006-2011
    NIH RO1 | MRI studies of angiogenesis in ovarian cancer.
  • 2005-2008
    Minerva Foundation Ferritin as a reporter gene for MRI
  • 2002-2006
    Israel Academy of Science | Non invasive MRI tracking of cell
    recruitment in angiogenesis
  • 2001-2006
    NIH RO1 | MRI studies of angiogenesis in ovarian cancer.
  • 2001-2004
    NIH-RO1 | Imaging lymphatic clearance in tumor metastasis
    (PI Bhujwalla, Zaver; Subcontract PI Neeman)
  • 2001-2005
    Varian Biosynergy New Bioactive Contrast Material for Molecular Imaging of
    tumor angiogenesis and tumor boundaries
    (with Mark W. Dewhirst, Duke University, Durham, NC)
  • 2000-2001
    Israel Ministry of Health | Mathematical modeling of tumor angiogenesis
    (with Z. Agur, IMBM)
  • 2000-2001
    CapCure Induction of blood vessel regression in prostate cancer and its
    imaging by MRI     (with E. Keshet, Hebrew University, Jerusalem)
  • 1998-2001
    NIH RO1 | MRI studies of angiogenesis in ovarian cancer
  • 1998
    Forchheimer Center for Molecular Biology In vivo mapping of activated
    gene expression by MRI
  • 1997-2000
    Minerva | Control of angiogenesis in the rat ovarian follicle : NMR studies
  • 1996-1997
    Frenkel Foundation Gonadotropin effect on neovascularization of ovarian
    carcinoma:  NMR microimaging studies
  • 1996-1999
    Israel Academy of Science Intra- and intercellular diffusion mapping during
    stress induced angiogenesis: High resolution NMR microscopy
  • 1994-1995
    Frenkel Foundation A model for tumor angiogenesis:
    Magnetic resonance microimaging
  • 1994-1997
    United States - Israel Binational Science Foundation
    Microenvironmental effects on tumor angiogenesis: NMR microscopy 
    of multicellular spheroids (with JP Freyer, LANL)
  • 1994-1999
    Israel Cancer Research Fund - Research Career Development Award
    Microenvironmental stress in ovarian cancer:  MRI and MRS
  • 1995-1996
    Israel Cancer Association | Gonadotropin role in ovarian tumor angiogenesis
  • 1994-1997
    Minerva | NMR microscopy studies of ovarian follicular physiology
  • 1993-1995
    Alon Fellowship
  • 1992-1993
    Frenkel Foundation
  • 1992-1993
    Mijan Foundation
  • 1992
    Wolfson Fund | Equipment funding- NMR microscopy
  • 1992
    Israel Academy of Science | Equipment funding- NMR microscopy